SCHEMBL28296067

SCHEMBL28296067

COC(=O)c1cnc(CC(C)=O)[nH]1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.58
MAPK1 P28482 2/20 0.38
CYP1A2 P05177 1/20 0.38
KDM4E B2RXH2 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
XDH P47989 1/20 0.36
ALDH1A1 P00352 2/20 0.35
ABL1 P00519 8/20 0.34
SRC P12931 7/20 0.34
BAZ2B Q9UIF8 1/20 0.34
BAZ2A Q9UIF9 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
TSHR P16473 1/20 0.33
ALPL P05186 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28296065 0.84 MMP2 (0.56) MMP2MAPK1CYP1A2KDM4EGLA
SCHEMBL7424608 0.83 MMP2 (0.61) MMP2MAPK1CYP1A2KDM4EGLA
SCHEMBL4605593 0.81 MMP2 (0.60) MMP2MAPK1CYP1A2KDM4EGLA
SCHEMBL20630811 0.81 MMP2 (0.60) MMP2MAPK1CYP1A2KDM4EGLA
SCHEMBL14744177 0.80 MMP2 (0.67) MMP2MAPK1CYP1A2KDM4EGLA
SCHEMBL31373939 0.80 MMP2 (0.58) MMP2MAPK1CYP1A2KDM4EGLA
SCHEMBL8653203 0.80 MMP2 (0.67) MMP2MAPK1CYP1A2KDM4EGLA
Hydrochloric Acid SCHEMBL14744176 0.79 MMP2 (0.65) MMP2MAPK1CYP1A2KDM4EGLA
SCHEMBL9605532 0.78 MMP2 (0.56) MMP2MAPK1CYP1A2KDM4EGLA
SCHEMBL8225066 0.76 MMP2 (0.50) MMP2MAPK1CYP1A2KDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843884-A IMIDAZOPYRAZINONES, PYRAZOLOPYRIMIDINONES AND PYRAZOLOPYRIDINONES AS PDE1 INHIBITORS H.隆德贝克有限公司 2019-06-04 CN disclosed
CN-109803658-A Combined therapy comprising the Imidazopyrazines ketone for treating mental disease and/or cognitive disorder H.隆德贝克有限公司 2019-05-24 CN disclosed
CN-109803653-A Combined therapy including giving Imidazopyrazines ketone H.隆德贝克有限公司 2019-05-24 CN disclosed